CSPC Innovation Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 300765.SZ

CSPC Innovation Pharmaceutical Co., Ltd. Total Assets for the year ending December 31, 2023: USD 793.28 M

CSPC Innovation Pharmaceutical Co., Ltd. Total Assets is USD 793.28 M for the year ending December 31, 2023, a 19.42% change year over year. Total assets are the total value of all assets owned by a company, representing its resources.

CSPC Innovation Pharmaceutical Co., Ltd. Total Assets for the year ending December 31, 2022 was USD 664.27 M, a 30.85% change year over year.
CSPC Innovation Pharmaceutical Co., Ltd. Total Assets for the year ending December 31, 2021 was USD 507.67 M, a 12.15% change year over year.
CSPC Innovation Pharmaceutical Co., Ltd. Total Assets for the year ending December 31, 2020 was USD 452.69 M, a 10.52% change year over year.
CSPC Innovation Pharmaceutical Co., Ltd. Total Assets for the year ending December 31, 2019 was USD 409.60 M, a 102.55% change year over year.

Key data

Date	Total Assets	Current Liabilities	Total Non-Current Liabilities	Shareholders' Equity

Shenzhen Stock Exchange: 300765.SZ

CSPC Innovation Pharmaceutical Co., Ltd.

CEO	Mr. Feng Han
IPO Date	March 22, 2019
Location	China
Headquarters	No. 36, Fuqiang Western Road
Employees	1,887
Sector	Consumers Staples
Industries Non-Alcoholic Beverages Alcoholic Beverages Consumer Packaged Goods Drugstores & Retail Pharmacies Pharmaceuticals Soft Drinks & Sodas Tobacco

Description

CSPC Innovation Pharmaceutical Co., Ltd. manufactures and sells caffeine, and vitamin C health supplement and beverage products. The company is based in Shijiazhuang, China. CSPC Innovation Pharmaceutical Co., Ltd. is a subsidiary of CSPC Pharmaceutical Group Limited.

Key trends

Past 5 years